Cost analysis of colorectal cancer (CRC) management in UKM Medical Centre using clinical pathway

Mohd, Natrah; Ezat, Sharifa; Aljunid, Syed Mohamed; Manaf, Mohd Rizal Abdul; Sulong, Saperi; Sagap, Ismail; M, Azrif

doi:10.1186/1471-2458-12-s2-a40

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Referring to the literature reviews by researchers from both Thailand and internationally, there has been no research studying the cost of breast cancer, liver cancer and colorectal cancer. However, an international literature review found research from Mohd, et al [13], who studied the cost of colorectal cancer, but it was in a different context, and due to the progression of therapy technology, only some information can be used as reference. Additionally, most studies references the Activity-Based Costing method [14], [15], [16].…”

Section: Literature Reviewmentioning

confidence: 99%

The Application of Activity-Based Costing for Public Hospital Sector Sustainability

Aujirapongpan¹,

Promma²,

Theinsathid³

et al. 2020

Journal of Southwest Jiaotong University

View full text Add to dashboard Cite

The research objective is to analyse the cost by the application of Activity-Based Costing of the cancer treatment process at a Thai public hospital by comparing the cost of cancer treatment with the compensation received from the National Health Security Office to set sustainability policy. Historical data were collected from 698, 295 and 348 cases of patients with breast cancer, liver cancer and colorectal cancer, respectively, from 1 October 2017 to 30 September 2018 by creating a matrix of coefficients and constants.The results showed that the cost of breast cancer treatment included the costs of 5 activities: breast cancer surgery, radiation, chemotherapy, the use of anti-hormone drugs and the treatment at the targeted cancer. The costs for the treatment of liver cancer included the costs of 5 activities: liver cancer surgery, TACE, radiation, chemotherapy and the treatment at the targeted cancer.And the cost of the treatment of colorectal cancer included the costs of 3 activities: colon cancer surgery, radiation and the use of chemotherapy.The treatments were found that the cost calculated from the activity-based were higher than the compensation received from the National Health Security Office. The research data constitute useful information for executives involved in policy makingabout managing and resources allocation to be the most appropriate and cost-effectiveness for sustainability of public hospitals in Thailand.

show abstract

Section: Literature Reviewmentioning

confidence: 99%

The Application of Activity-Based Costing for Public Hospital Sector Sustainability

Aujirapongpan¹,

Promma²,

Theinsathid³

et al. 2020

Journal of Southwest Jiaotong University

View full text Add to dashboard Cite

show abstract

“…As the global burden of CRCs is expected to be commensurate with population aging, the costs of cancer treatments are projected to escalate simultaneously [23][24][25][26][27][28][29][30][31][32]. CRC treatment costs and expenditures can be reduced significantly if screening efforts are carried out early, actively, and rigorously [33,34].…”

Section: Introductionmentioning

confidence: 99%

Cost-Effectiveness of Colorectal Cancer Genetic Testing

Ramdzan

Manaf

Aizuddin

et al. 2021

IJERPH

View full text Add to dashboard Cite

Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths worldwide. Approximately 3–5% of CRCs are associated with hereditary cancer syndromes. Individuals who harbor germline mutations are at an increased risk of developing early onset CRC, as well as extracolonic tumors. Genetic testing can identify genes that cause these syndromes. Early detection could facilitate the initiation of targeted prevention strategies and surveillance for CRC patients and their families. The aim of this study was to determine the cost-effectiveness of CRC genetic testing. We utilized a cross-sectional design to determine the cost-effectiveness of CRC genetic testing as compared to the usual screening method (iFOBT) from the provider’s perspective. Data on costs and health-related quality of life (HRQoL) of 200 CRC patients from three specialist general hospitals were collected. A mixed-methods approach of activity-based costing, top-down costing, and extracted information from a clinical pathway was used to estimate provider costs. Patients and family members’ HRQoL were measured using the EQ-5D-5L questionnaire. Data from the Malaysian Study on Cancer Survival (MySCan) were used to calculate patient survival. Cost-effectiveness was measured as cost per life-year (LY) and cost per quality-adjusted life-year (QALY). The provider cost for CRC genetic testing was high as compared to that for the current screening method. The current practice for screening is cost-saving as compared to genetic testing. Using a 10-year survival analysis, the estimated number of LYs gained for CRC patients through genetic testing was 0.92 years, and the number of QALYs gained was 1.53 years. The cost per LY gained and cost per QALY gained were calculated. The incremental cost-effectiveness ratio (ICER) showed that genetic testing dominates iFOBT testing. CRC genetic testing is cost-effective and could be considered as routine CRC screening for clinical practice.

show abstract

Colorectal cancer in Malaysia: Its burden and implications for a multiethnic country

Veettil

Lim

Chaiyakunapruk

et al. 2017

Asian Journal of Surgery

View full text Add to dashboard Cite

The efficiency of different screening approaches must be assessed, and an organized national screening program should be developed in a phased manner. It is essential to maintain a balanced investment in awareness programs targeting general population and primary care providers, focused on increasing the knowledge on symptoms and risk factors of colorectal cancer, awareness on benefits of screening, and promotion of healthy life styles to prevent this important disease.

show abstract

Cost analysis of colorectal cancer (CRC) management in UKM Medical Centre using clinical pathway

Cited by 3 publications

References 0 publications

The Application of Activity-Based Costing for Public Hospital Sector Sustainability

The Application of Activity-Based Costing for Public Hospital Sector Sustainability

Cost-Effectiveness of Colorectal Cancer Genetic Testing

Colorectal cancer in Malaysia: Its burden and implications for a multiethnic country

Contact Info

Product

Resources

About